EUV Lithography Adoption Accelerates Formulation Investment
EUV photoresist formulations are gaining foundry capital investment as leading-edge semiconductor manufacturers respond to sustained sub-5-nanometer node scaling requirements across major fabrication markets. Several leading producers have documented EUV formulation qualification wins tied directly to foundry capacity expansion announced over the past several years. This shift gives producers with established EUV chemistry expertise a genuine advantage over competitors reliant purely on mature-node formulations. Adoption is expected to accelerate through 2029 across most major leading-edge fabrication regions, supported by continued foundry investment in advanced node capacity. Retailers have responded by expanding shelf space for these fortified lines across most major categories.
Market Impact: Adds 12 percent volume growth








